Bentley InnoMed GmbH announced CE Mark approval for the company’s BeGraft Plus for use as a bridging stent graft in bran ...

Gore & Associates and Egg Medical announced findings from a national poll on the concerns regarding radiation exposure in ...

Terumo Aortic announced enrollment of the first patient in the fenestrated TREO pivotal trial in the United States. Accordi ...

Vexev and U.S. Renal Care announced the results of the CANSCAN feasibility trial, which provided evidence that Vexev’s V ...

RapidAI announced FDA clearance of Aortic Management, part of the company’s Rapid Aortic product, a clinical artificial ...

Surmodics, Inc. announced that it expects to close promptly the previously announced acquisition (“merger”) of the ...

Vesalio announced two FDA 510(k) clearances for its aspiration devices for peripheral and neurovascular applications, ...

Neurotronic, Inc. announced the first clinical outcomes of the NECTAR III and NECTAR IV trials evaluating the company’s ...

ViTAA Medical Solutions Inc. announced that the FDA has granted 510(k) clearance for the company’s AiORTA Plan. Accor ...

CUC Inc., a provider of health care management and operational support services headquartered in Tokyo, Japan, announced it ...

Johnson & Johnson MedTech announced the 1-year results from the FORWARD PAD study of its Shockwave Javelin peripheral intr ...

In this retrospective cohort study designed to assess long-term safety outcomes of drug-coated devices (DCDs) versus ...